The current status of adjuvant treatment for high-risk renal cell carcinoma

被引：0
|
作者：
Hizal, Mutlu [1 ]
Sendur, Mehmet A. N. [1 ]
Bilgin, Burak [1 ]
Akinci, Muhammed Bulent [1 ]
Dede, Didem Sener [1 ]
Yalcin, Bulent [1 ]
机构：
[1] Yildirim Beyazit Univ, Dept Med Oncol, Ankara, Turkey
来源：
FUTURE ONCOLOGY | 2017年 / 13卷 / 23期
关键词：
renal cell carcinoma; adjuvant treatment; tyrosine kinase inhibitors; TYROSINE KINASE INHIBITORS; SUNITINIB; THERAPY;
D O I：
10.2217/fon-2017-0352
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2017 / 2020
页数：4
相关论文
共 50 条
  • [1] Adjuvant Treatment of High-risk Renal Cell Carcinoma: Leaving the Desert?
    Kroeger, Nils
    Stenzl, Arnulf
    Burchardt, Martin
    Bedke, Jens
    EUROPEAN UROLOGY, 2017, 71 (05) : 695 - 696
  • [2] Adjuvant treatment of high-risk renal cell carcinoma: the jury is still out
    Procopio, G.
    Sepe, P.
    Verzoni, E.
    Pignata, S.
    Bamias, A.
    ANNALS OF ONCOLOGY, 2018, 29 (10) : 2030 - 2032
  • [3] Adjuvant treatment for renal cell carcinoma: current status and future
    Leung, David K. W.
    Siu, Brian W. H.
    Teoh, Jeremy Y. C.
    CURRENT OPINION IN UROLOGY, 2025, 35 (01) : 41 - 45
  • [4] The Current State of Adjuvant Therapy Following Surgery for High-risk Renal Cell Carcinoma
    Ridyard, Douglas G.
    Buller, Dylan M.
    Ristau, Benjamin T.
    EUROPEAN UROLOGY FOCUS, 2019, 5 (06): : 935 - 938
  • [5] Overview of Current and Future Adjuvant Therapy for High-Risk Localized Renal Cell Carcinoma
    Nandagopal, Lakshminarayanan
    Naik, Gurudatta
    Sonpavde, Guru
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2018, 19 (01)
  • [6] Overview of Current and Future Adjuvant Therapy for High-Risk Localized Renal Cell Carcinoma
    Lakshminarayanan Nandagopal
    Gurudatta Naik
    Guru Sonpavde
    Current Treatment Options in Oncology, 2018, 19
  • [7] Adjuvant and Neoadjuvant Therapies in High-Risk Renal Cell Carcinoma
    Smaldone, Marc C.
    Fung, Chunkit
    Uzzo, Robert G.
    Haas, Naomi B.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2011, 25 (04) : 765 - +
  • [8] Adjuvant therapy for high-risk renal cell carcinoma patients
    Kunkle D.A.
    Haas N.B.
    Uzzo R.G.
    Current Urology Reports, 2007, 8 (1) : 19 - 30
  • [9] Adjuvant Therapy for Localized High-Risk Renal Cell Carcinoma
    Wood, Erika
    Donin, Nicholas
    Shuch, Brian
    UROLOGIC CLINICS OF NORTH AMERICA, 2020, 47 (03) : 345 - +
  • [10] Adjuvant multipeptide vaccination in high-risk renal cell carcinoma
    Feyerabend, S.
    Gouttefangeas, C.
    Stevanovic, S.
    Wernet, D., Sr.
    Hennenlotter, J.
    Bedke, J.
    Droege, A.
    Laske, K.
    Rammensee, H.
    Stenzl, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345